When.com Web Search

  1. Ads

    related to: alternative to flagyl for trichomoniasis in dogs cost

Search results

  1. Results From The WOW.Com Content Network
  2. Antitrichomonal agent - Wikipedia

    en.wikipedia.org/wiki/Antitrichomonal_agent

    An antitrichomonal agent is an antiprotozoal agent that acts on trichomonas parasites. [1] Examples include: [2] furazolidone; nifuratel; nimorazole; ornidazole ...

  3. Tinidazole - Wikipedia

    en.wikipedia.org/wiki/Tinidazole

    Tinidazole, sold under the brand name Tindamax among others, is a medication used against protozoan infections.It is widely known throughout Europe and the developing world as a treatment for a variety of anaerobic amoebic and bacterial infections.

  4. Marbofloxacin - Wikipedia

    en.wikipedia.org/wiki/Marbofloxacin

    Marbofloxacin is a carboxylic acid derivative third generation fluoroquinolone antibiotic. It is used in veterinary medicine under the brand names Marbocyl , Forcyl, Marbo vet and Zeniquin . A formulation of marbofloxacin combined with clotrimazole and dexamethasone is available under the name Aurizon ( CAS number 115550-35-1).

  5. Metronidazole - Wikipedia

    en.wikipedia.org/wiki/Metronidazole

    Metronidazole, sold under the brand name Flagyl among others, is an antibiotic and antiprotozoal medication. [10] It is used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis. [10] It is effective for dracunculiasis, giardiasis, trichomoniasis, and amebiasis. [10]

  6. Antiparasitic - Wikipedia

    en.wikipedia.org/wiki/Antiparasitic

    Metronidazole (for vaginitis caused by Trichomonas) ... triazolopyrimidines and their metal complexes have been looked at as an alternative drug to the existing ...

  7. Nitazoxanide - Wikipedia

    en.wikipedia.org/wiki/Nitazoxanide

    Nitazoxanide alone has shown preliminary evidence of efficacy in the treatment of chronic hepatitis B over a one-year course of therapy. [17] Nitazoxanide 500 mg twice daily resulted in a decrease in serum HBV DNA in all of 4 HBeAg-positive patients, with undetectable HBV DNA in 2 of 4 patients, loss of HBeAg in 3 patients, and loss of HBsAg in one patient.